CT Radiomics for Predicting Immunotherapy Efficacy in Non-Small Cell Lung Cancer
For driver-negative advanced non-small cell lung cancer (NSCLC), immune checkpoint inhibitors (ICIs) have been established as the standard therapy, but only a few patients can achieve lasting clinical benefits, and reliable non-invasively predictive tools are urgently needed in clinical practice. CT radiomics can non-i...